UBS Group’s Heron Therapeutics HRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.59M | Buy |
3,184,965
+3,026,226
| +1,906% | +$6.26M | ﹤0.01% | 2822 |
|
|
2025
Q1 | $349K | Sell |
158,739
-737
| -0.5% | -$1.62K | ﹤0.01% | 4921 |
|
|
2024
Q4 | $244K | Buy |
159,476
+74,223
| +87% | +$114K | ﹤0.01% | 5142 |
|
|
2024
Q3 | $170K | Sell |
85,253
-81,540
| -49% | -$162K | ﹤0.01% | 4822 |
|
|
2024
Q2 | $584K | Buy |
166,793
+55,399
| +50% | +$194K | ﹤0.01% | 3826 |
|
|
2024
Q1 | $309K | Sell |
111,394
-10,082
| -8% | -$27.9K | ﹤0.01% | 4420 |
|
|
2023
Q4 | $207K | Buy |
121,476
+58,410
| +93% | +$99.3K | ﹤0.01% | 4582 |
|
|
2023
Q3 | $65K | Sell |
63,066
-5,971
| -9% | -$6.15K | ﹤0.01% | 5000 |
|
|
2023
Q2 | $80.1K | Buy |
69,037
+13,269
| +24% | +$15.4K | ﹤0.01% | 5128 |
|
|
2023
Q1 | $84.2K | Buy |
55,768
+18,875
| +51% | +$28.5K | ﹤0.01% | 4979 |
|
|
2022
Q4 | $92.2K | Sell |
36,893
-50,994
| -58% | -$127K | ﹤0.01% | 5058 |
|
|
2022
Q3 | $372K | Buy |
87,887
+79,826
| +990% | +$338K | ﹤0.01% | 3605 |
|
|
2022
Q2 | $22K | Sell |
8,061
-226,059
| -97% | -$617K | ﹤0.01% | 5730 |
|
|
2022
Q1 | $1.34M | Sell |
234,120
-85,137
| -27% | -$487K | ﹤0.01% | 2985 |
|
|
2021
Q4 | $2.92M | Buy |
319,257
+71,149
| +29% | +$650K | ﹤0.01% | 2569 |
|
|
2021
Q3 | $2.65M | Buy |
248,108
+239,993
| +2,957% | +$2.57M | ﹤0.01% | 2544 |
|
|
2021
Q2 | $126K | Sell |
8,115
-139,789
| -95% | -$2.17M | ﹤0.01% | 4675 |
|
|
2021
Q1 | $2.4M | Buy |
147,904
+16,454
| +13% | +$267K | ﹤0.01% | 2608 |
|
|
2020
Q4 | $2.78M | Buy |
131,450
+39,866
| +44% | +$844K | ﹤0.01% | 2348 |
|
|
2020
Q3 | $1.36M | Sell |
91,584
-22,795
| -20% | -$338K | ﹤0.01% | 2724 |
|
|
2020
Q2 | $1.68M | Sell |
114,379
-10,941
| -9% | -$161K | ﹤0.01% | 2411 |
|
|
2020
Q1 | $1.47M | Buy |
125,320
+26,784
| +27% | +$314K | ﹤0.01% | 2397 |
|
|
2019
Q4 | $2.32M | Sell |
98,536
-142,312
| -59% | -$3.34M | ﹤0.01% | 2651 |
|
|
2019
Q3 | $4.46M | Buy |
240,848
+61,140
| +34% | +$1.13M | ﹤0.01% | 1943 |
|
|
2019
Q2 | $3.34M | Buy |
179,708
+122,805
| +216% | +$2.28M | ﹤0.01% | 2116 |
|
|
2019
Q1 | $1.39M | Sell |
56,903
-148,476
| -72% | -$3.63M | ﹤0.01% | 2692 |
|
|
2018
Q4 | $5.33M | Buy |
205,379
+118,661
| +137% | +$3.08M | ﹤0.01% | 1650 |
|
|
2018
Q3 | $2.75M | Buy |
86,718
+34,942
| +67% | +$1.11M | ﹤0.01% | 2358 |
|
|
2018
Q2 | $2.01M | Sell |
51,776
-167,024
| -76% | -$6.49M | ﹤0.01% | 2541 |
|
|
2018
Q1 | $6.04M | Buy |
218,800
+179,364
| +455% | +$4.95M | ﹤0.01% | 1711 |
|
|
2017
Q4 | $714K | Sell |
39,436
-6,047
| -13% | -$109K | ﹤0.01% | 3225 |
|
|
2017
Q3 | $734K | Buy |
45,483
+14,963
| +49% | +$241K | ﹤0.01% | 3207 |
|
|
2017
Q2 | $423K | Buy |
30,520
+18,966
| +164% | +$263K | ﹤0.01% | 3450 |
|
|
2017
Q1 | $173K | Sell |
11,554
-33,102
| -74% | -$496K | ﹤0.01% | 3890 |
|
|
2016
Q4 | $585K | Buy |
44,656
+35,686
| +398% | +$467K | ﹤0.01% | 3199 |
|
|
2016
Q3 | $155K | Sell |
8,970
-197,002
| -96% | -$3.4M | ﹤0.01% | 3895 |
|
|
2016
Q2 | $3.72M | Buy |
205,972
+66,349
| +48% | +$1.2M | ﹤0.01% | 1741 |
|
|
2016
Q1 | $2.65M | Sell |
139,623
-211,584
| -60% | -$4.02M | ﹤0.01% | 1925 |
|
|
2015
Q4 | $9.38M | Buy |
351,207
+39,978
| +13% | +$1.07M | 0.01% | 1112 |
|
|
2015
Q3 | $7.59M | Buy |
311,229
+70,179
| +29% | +$1.71M | 0.01% | 1224 |
|
|
2015
Q2 | $7.51M | Buy |
241,050
+239,612
| +16,663% | +$7.47M | 0.01% | 1321 |
|
|
2015
Q1 | $21K | Sell |
1,438
-165
| -10% | -$2.41K | ﹤0.01% | 5346 |
|
|
2014
Q4 | $16K | Buy |
+1,603
| New | +$16K | ﹤0.01% | 5738 |
|